Freedom Broker Maintains Buy on Niagen Bioscience, Lowers Price Target to $6
Benzinga Newsdesk 22 hours ago
Analyst RatingsNewsPrice Target
Freedom Broker analyst Ilya Zubkov maintains Niagen Bioscience (NASDAQ:NAGE) with a Buy and lowers the price target from $8.5 to $6.
Freedom Broker analyst Ilya Zubkov maintains Niagen Bioscience (NASDAQ:NAGE) with a Buy and lowers the price target from $8.5 to $6.